)
Osaka Soda Co (4046) investor relations material
Osaka Soda Co Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
H1 net sales rose 14.8% YoY to ¥56,082m; operating profit rose 33.6% to ¥10,836m, both record highs for the period.
Ordinary profit increased 29.9% to ¥11,572m and profit attributable to owners of parent rose 18.7% to ¥8,016m.
Financial highlights
Gross profit was ¥19,619m versus ¥15,951m YoY; SG&A rose to ¥8,783m from ¥7,840m.
Comprehensive income increased to ¥11,288m from ¥8,270m, including ¥3,272m of other comprehensive income.
Extraordinary income was ¥132m versus ¥877m YoY; current-period profit included ¥180m of losses on retirement of non-current assets.
Outlook and guidance
FY27 forecast unchanged: net sales ¥108,000m, operating profit ¥20,500m, ordinary profit ¥22,100m and profit attributable to owners of parent ¥14,800m.
FY27 forecast EPS is ¥121.74; interim dividend is ¥16/share and forecast year-end dividend is ¥16/share, for ¥32/share annually, revised from the prior forecast.
Pharmaceutical purification capacity at Amagasaki and Matsuyama is targeted to approximately double by February 2028.
- Healthcare-driven growth and innovation underpin ambitious profit and shareholder return targets.4046
Corporate presentation - Record quarterly profits and sales driven by robust healthcare and chemical segment growth.4046
Q1 2027 - Profits and sales rose on strong healthcare and chemicals demand; stock split set for October.4046
Q1 2025 - Operating profit jumped 41.7% on 7.6% higher sales, led by healthcare and functional chemicals.4046
Q2 2025 - Profits surged on strong healthcare demand and supply recovery; full-year outlook maintained.4046
Q3 2025 - Profits surged on healthcare growth and supply recovery, with record highs forecast for FY2025 and FY2026.4046
Q4 2025 - First-quarter profit rose 9.4% year-on-year, driven by healthcare and basic chemicals growth.4046
Q1 2026 - Profits rose sharply despite lower sales, with upward guidance and enhanced shareholder returns.4046
Q2 2026 - Record profits and sales driven by Basic Chemicals and Healthcare, with robust cash flow and new growth plans.4046
Q4 2026
Next Osaka Soda Co earnings date
Next Osaka Soda Co earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)